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Abstract 
 
CHARACTERIZING THE DOMAINS OF THE BIOFILM REGULATOR MBAA IN 
VIBRIO CHOLERAE 
 
Whitney Gabrielle Bond 
B.Sc., University of North Carolina Wilmington 
M.A., Appalachian State University 
 
 
Chairperson: Dr. Ece Karatan 
 
 
 Vibrio cholerae is an aquatic, intestinal pathogen that is believed to survive within its 
natural environment in a biofilm state but can only cause infection in a planktonic, motile 
state. This bacterium is able to switch between states by sensing signals within its 
environment. Polyamines, specifically norspermidine, spermidine, and spermine, modulate 
biofilm formation. Spermine and spermidine decrease biofilm formation and are found in the 
human intestine, while norspermidine increase biofilm formation and is found in the 
environment. All three polyamines are sensed by the periplasmic protein NspS, when NspS 
binds to a polyamine it is hypothesized to bind to the periplasmic region of MbaA, which is 
able to transduce a signal into the cytoplasm. MbaA is an integral membrane protein that has 
C-terminal tandem GGDEF and EAL domains. GGDEF and EAL domains are associated 
with diguanylate cyclase and phosphodiesterase activity, respectively. Diguanylate cyclases 
produce the secondary messenger c-di-GMP from GTP while phosphodiesterases break down 
c-di-GMP. Increasing intracellular c-di-GMP enhances biofilm formation. Our lab has 
previously characterized MbaA as a phosphodiesterase. This current study set out to 
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determine the purpose of the GGDEF domain within MbaA. The parts of the mbaA gene that 
encode the GGDEF and EAL domains were amplified by PCR and then cloned into pMAL-
c5x. This enabled the expression of GGDEF and EAL domains as maltose binding protein 
(MBP) fusions. MBP-GGDEF and MBP-EAL proteins were purified and used to determine 
diguanylate cyclase and phosphodiesterase activities. High Pressure Liquid Chromatography 
(HPLC) was then used to determine reaction products. The EAL domain was determined to 
be independently functional in vitro and the GGDEF domain has no apparent activity. 
Chromosomal deletions of each domain were done to further characterize the domains. EAL 
and GGDEF domain deletions have similar phenotypes to the mbaA background. This 
indicates that both domains are necessary for phosphodiesterase function in vivo. The 
domains were then deleted within an overexpression plasmid pMbaA to further characterize 
its effect on biofilm formation. pMbaAΔGGDEF had a decreased biofilm formation similar 
to that of the biofilm formation of pMbaA. pMbaAΔEAL had an increased biofilm formation 
similar to that of a ΔmbaA mutant. This indicates that the GGDEF domain is not necessary 
for phosphodiesterase activity and confirms in vitro results. 
Keywords Vibrio cholerae; biofilm; phosphodiesterase; diguanylate cyclase; c-di-GMP 
turnover; GGDEF-EAL protein. 
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Introduction 
 
Vibrio cholerae as a pathogen 
Vibrio cholerae is a Gram-negative bacterium that is the cause of the human intestinal 
disease cholera. Infections begin with the ingestion of contaminated water and foodstuffs and 
progresses to a watery diarrhea (Faruque et al., 1998, Reidl & Klose, 2002). The body fluid 
loss can be as much as 20 L a day in adults and can lead to death in as few as 12 hours after 
first symptoms occur (Faruque et al., 1998). Cholera infections were first documented in 
India in 1817 and spread throughout the world with infections reported in Europe and North 
America in the early 1900s (Faruque et al., 1998, Reidl & Klose, 2002). Modern sanitation 
systems prevent cholera outbreaks from happening today in developed countries; however, 
developing countries such as India, Bangladesh, and parts of Africa still see deadly outbreaks 
(Faruque et al., 1998). The World Health Organization estimates 1.3 million to 4.0 million 
cases of cholera happen worldwide each year with 21,000 to 143,000 of those infections 
ending in death. It is believed that there could be 100 times more cases that go unreported 
(Faruque et al., 1998, WHO, 2018). The deadliness of this bacteria and how it persists within 
the environment are research topics still being examined today. 
V. cholerae is found in many riverine, estuarine, and marine environments across the 
world and it is estimated to become more abundant as temperatures continue to warm (Kierek 
& Watnick, 2003, Escobar et al., 2015). It is thought that V. cholerae is able to persist within 
the environment through its ability to form a community-based, sedentary state called a 
 
2 
 
biofilm (Reidl & Klose, 2002, Kierek & Watnick, 2003). Biofilms have been shown to 
provide bacteria with protection from predators, osmotic stress, UV radiation, extreme pH, 
and the host immune system (Elasri & Miller, 1999, Prigent-Combaret et al., 1999, Donlan & 
Costerton, 2002, McNeill & Hamilton, 2003). This biofilm state is not only hypothesized to 
help survival of V. cholerae in the environment but also to facilitate the beginning of cholera 
infections. In order to start an infection, V. cholerae has to pass through the gastric barrier to 
make it into the small intestine. It is thought that the biofilm’s protective nature aids bacteria 
in surviving through the acidic pH of the stomach because V. cholerae in biofilms are 1,000-
fold more resistant to low pH compared to bacteria in a planktonic state (Zhu & Mekalanos, 
2003). Once the V. cholerae progress into the small intestine the bacteria need to disperse out 
of the biofilm and become motile and solitary planktonic cells in order to start expressing the 
essential virulence factors: cholerae toxin (CT) and toxin-coregulated pilus (TCP) (Reidl & 
Klose, 2002, Teschler et al., 2015).  TCP is required for colonization and infection. It is 
believed to bind to the intestinal epithelial cells and play a part in microcolony formation  
(Silva & Benitez, 2016). CT is an A-B type protein toxin that causes the characteristic 
profuse watery diarrhea seen in cholera infections. The B subunit binds to the GM1 
ganglioside receptors in the intestine (Holmgren et al., 1975, Vanden Broeck et al., 2007). 
The whole toxin is then absorbed into the cell where several CT proteins will cluster in the 
endoplasmic reticulum (ER); when it is in the ER, the A subunit splits from the B subunit 
(Holmgren et al., 1975, Vanden Broeck et al., 2007, Sanchez & Holmgren, 2011). This 
dissociation activates the enzymatic activity of the A subunit. The A subunit then moves 
back to the cytosol and uses NAD+ to ADP ribosylate the α subunit of a stimulatory G protein 
(Gsα) that regulates the activity of adenylate cyclase. ADP ribosylation of Gsα results in 
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constitutive activation adenylate cyclase which increases cyclic AMP levels in the host cell. 
This results in protein kinase A phosphorylating a chloride ion channel causing an increase in 
secretion of chloride ions followed by secretion of water out of the cells, leading to the 
watery diarrhea seen in cholera infections (Sanchez & Holmgren, 2011). As the disease 
progresses, V. cholerae is passed in the stools of patients (Reidl & Klose, 2002, Teschler et 
al., 2015). The idea that V. cholerae must be in the biofilm to survive stressors but planktonic 
to cause disease suggests that the switch between biofilm and planktonic state must be highly 
regulated (Teschler et al., 2015). 
C-di-GMP regulation within V. cholerae  
In order to regulate this switch between biofilm and planktonic states, V. cholerae 
uses environmental stimuli such as bile salts, temperatures, and polyamines (Conner et al., 
2017). V. cholerae senses these stimuli and then modulates the internal concentration of the 
second messenger cyclic diguanylate monophosphate (c-di-GMP). High c-di-GMP levels 
enhance biofilm formation and decrease the expression of both motility and virulence factors. 
C-di-GMP controls these phenotypes through its effects on transcription, translation, and 
protein function (Conner et al., 2017). 
C-di-GMP controls biofilm formation from the very beginning by controlling the 
attachment to a surface. V. cholerae uses the type IV pilus, MshA, to sense and then bind to 
appropriate surfaces to begin biofilm formation (Teschler et al., 2015, Conner et al., 2017).  
This pilus is formed by polymerization of MshA subunits with the energy being provided by 
the AAA+ ATPase MshE. The MshE domain, MshEN, binds to c-di-GMP and activates the 
polymerization of MshA subunits (Fig. 1a) (Wang et al., 2016). After the cells have attached 
themselves to a favorable surface, they begin producing biofilm matrix components such as 
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Vibrio polysaccharide (VPS) and extracellular proteins. This matrix joins cells together and 
is a necessary part of the biofilm. The genes that encode the extracellular proteins and the 
VPS synthesizing proteins are controlled by the biofilm master regulator VpsR (Fig. 1 B). 
While VpsR can bind to c-di-GMP, this binding is not critical for DNA binding which is 
required to activate transcription. The significance of VpsR binding to c-di-GMP has yet to 
be elucidated (Teschler et al., 2015, Conner et al., 2017). VpsR also is necessary for the 
expression of the accessory biofilm transcriptional regulator VpsT (Srivastava et al., 2011). 
VpsT then increases the transcription of vpsR, vpsT, vps genes, and genes related to 
extracellular proteins, such as rbmA and rbmB (Fig. 1b). VpsT is a homodimer and this 
dimerization is thought to be stabilized by the binding of 2 intertwined c-di-GMP molecules 
(Conner et al., 2017). The binding of c-di-GMP to VpsT is necessary for transcription of 
biofilm genes (Teschler et al., 2015, Conner et al., 2017). 
While c-di-GMP enhances biofilm formation, it represses motility. V. cholerae is able 
to move through its environment by a single polar flagellum. C-di-GMP controls flagellar 
activity both at the transcriptional and functional levels (Conner et al., 2017). The synthesis 
of the flagellum requires a multitude of proteins. The genes that encode these proteins are 
regulated by a four-level transcriptional hierarchy. The transcription of flagellar genes is 
initiated by the transcriptional activator FlrA. C-di-GMP binds to FlrA, inhibiting it from 
activating the flrBC operon, which in turn, inhibits flagellar production (Fig. 1c) (Srivastava 
et al., 2011). 
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Fig 1. c-di-GMP control of Vibrio cholerae. (a) c-di-GMP (    ) binds to the ATPase MshE 
which polymerizes the MshA subunits (dark gray bars). MshA is a pili necessary for surface 
attachment and biofilm formation. (b) VpsR and VpsT are transcriptional regulators that bind 
to promoter regions of biofilm genes such as vps-1 and vps-2 operons, rbmA and rbmC, and 
vpsT and vpsR. This leads to biofilm matrix production (c) c-di-GMP binds to the 
transcriptional regulator FlrA which prevents the flagellar genes flrB and flrC from being 
transcribed and causes the inhibition of motility. (d) VieA breaks c-di-GMP down which 
leads to the production of ToxT. This leads to production of cholera toxin (CT). 
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High c-di-GMP decreases the transcription of the master virulence transcription factor 
ToxT. ToxT activates the necessary virulence factors CT and TCP. The loss of a protein  
called VieA, which breaks down c-di-GMP, leads to an increase in c-di-GMP levels, and this 
leads to a decrease in ToxT levels and loss of colonization (Tischler & Camilli, 2005). VieA 
transcription is upregulated when cells adhered to intestinal epithelial cells which leads to a 
decrease in c-di-GMP and an increase in virulence gene expression (Dey et al., 2013). 
Synthesis and breakdown of c-di-GMP 
C-di-GMP levels in the cell are controlled by two classes of proteins: diguanylate 
cyclases and phosphodiesterases. Diguanylate cyclases circularize two guanosine tri-
phosphates to produce c-di-GMP; this enzyme is associated with a GGDEF (also called a 
GG(E/D)EF) domain. Phosphodiesterases are associated with the domains EAL and HD-
GYP; these enzymes break down c-di-GMP into linear 5'-phosphoguanylyl-(3',5')-guanosine 
(5’pGpG) and 2 guanosine monophosphate (GMP), respectively. These two classes of 
proteins control c-di-GMP concentration within the cell, regulating this switch between 
planktonic and biofilm states (Conner et al., 2017). 
The catalytic amino acids necessary for diguanylate cyclase activity were first 
characterized through the crystallization of the Caulobacter crescentus diguanylate cyclase 
PleD. GTP binds to the domain between two α helices with the ribosyl and α phosphates 
covering the glycines within the characteristic GGEEF motif (Chan et al., 2004). Glycines 
are the smallest amino acids which provide the ability for the GTP phosphates to cover the 
glycines of the GGDEF motif; this may be why the glycines within the GGDEF motifs are so 
highly conserved (Chan et al., 2004).  One GGDEF protein, ECA372, with a noncanonical 
SGDEF motif in Pectobacterium atrosepticum has been characterized as a diguanylate 
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cyclase. It is not yet known how this motif is able to bind to GTP; however, the ability of a 
noncanonical motif to bind GTP may indicate a flexibility of the binding site (Pérez-
Mendoza et al., 2011). For c-di-GMP to be formed, two GGDEF proteins must bind to GTP 
and then dimerize in an antiparallel fashion. This provides the right conformation for an 
intermolecular nucleophilic attack between one GTP and the α-phosphate group of the other 
GTP (Chan et al., 2004, Whiteley & Lee, 2015). Once the pyrophosphate leaving group 
disperses, c-di-GMP leaves to elicit its responses. 
The first EAL-domain phosphodiesterase to be crystallized was RocR of 
Pseudomonas aeruginosa. RocR has 8 alternating α helices and β strands along the backbone 
to form a triosephosphate isomerase (TIM)-barrel-like fold with the EAL (E175-A176-L177) 
domain located at the C-terminal part of the β barrel (Fig. 2) (Rao et al., 2008, Tchigvintsev 
et al., 2010). The c-di-GMP is bound within this barrel conformation and the secondary 
messenger is held in an extended conformation (Rao et al., 2008, Tchigvintsev et al., 2010, 
Bellini et al., 2017). EAL proteins can either bind a Mg2+ or manganese (Mn2+) to conduct 
phosphodiesterase activity, with Mg2+ thought to be more physiologically relevant (Schmidt 
et al., 2005, Rao et al., 2008). This Mg2+ ion coordinates an H2O molecule to be linear with 
the electrophilic phosphorous of c-di-GMP. The H2O molecule is deprotonated to produce a 
nucleophilic hydroxide ion. The deprotonated water engages in a nucleophilic attack onto the 
electrophilic phosphorous of c-di-GMP. This produces 5’pGpG, a linear nucleotide (Rao et 
al., 2008). 
HD-GYP domains are the second class of PDEs that break down c-di-GMP. They 
hydrolyze c-di-GMP into 2 GMP molecules. HD-GYPs are part of a large HD domain 
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subfamily of phosphomonoesterases and phosphodiesterase which use mono- or binuclear 
catalytic metal center to catalyze their respective reactions (Bellini et al., 2014).  
These c-di-GMP associated proteins have a high degree of redundancy, especially in 
Gram-negative bacteria. Vibrio cholerae, for instance, has 62 c-di-GMP associated proteins: 
31 GGDEF proteins, 12 EAL proteins, 9 HD-GYP proteins, and 10 tandem GGDEF-EAL 
proteins. Some of this redundancy can be explained with these proteins commonly being 
linked with sensory domains. These sensory domains modulate enzymatic function in 
accordance to environmental signals (Karatan & Watnick, 2009, Whiteley & Lee, 2015). 
There is also evidence for different enzymes having different rates of input and output to 
enable fine tuning of the phenotypes. This was established in diguanylate cyclases in V. 
cholerae as they can be characterized as either fast biofilm regulators or slow biofilm 
regulators based on how fast these enzymes affect vps gene transcription (Massie et al., 
2012). 
Tandem GGDEF-EAL proteins 
Tandem GGDEF-EAL proteins are seen in a multitude of bacterial species; a recent 
genomic analysis found that approximately one third all of proteins with GGDEF domains 
and approximately two thirds of those with EAL domains contained both GGDEF and EAL 
domains in tandem. In V. cholerae, approximately one sixth of the GGDEF/EAL proteins 
contain both domains. Despite the abundance of tandem GGDEF-EAL proteins, they are not 
well characterized; of the 4867 such proteins, only a handful have been characterized 
(Römling et al., 2013). The majority of tandem GGDEF-EAL proteins have been 
characterized in other bacterial species besides V. cholerae. It is important to note that the 
tandem GGDEF-EAL proteins do not necessarily indicate both diguanylate cyclase and 
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phosphodiesterase activity. Only three proteins have been characterized as dual-functional 
diguanylate cyclases and phosphodiesterases in bacteria: DcpA of Agrobacterium 
tumefaciens, ScrC of Vibrio parahaemolyticus, and BphG1 of Rhodobacter sphaeroides 
(Tarutina et al., 2006, Ferreira et al., 2008, Feirer et al., 2015). Many tandem GGDEF-EAL 
proteins have been characterized as active phosphodiesterases; in this case, the GGDEF 
domains of these proteins have either a regulatory role or are uncharacterized. For example, 
the C. crescentus GGDEF-EAL protein CC3396 is a phosphodiesterase with a noncanonical 
GGDEF domain (GEDEF) that can bind GTP. This binding of GTP activates the 
phosphodiesterase activity in CC3396; however, the physiological relevance of this 
activation is not currently understood. It is possible that a decrease in GTP concentration 
could be a stress response and indicates the need to turn off phosphodiesterase activity to 
avoid depleting the GTP pool. Another possibility is that a decrease in GTP would inhibit 
phosphodiesterase activity, increasing c-di-GMP concentration (Christen et al., 2005). 
Several other tandem GGDEF-EAL proteins have been characterized to have 
phosphodiesterase activity; however, the role of the GGDEF domains within the proteins 
remain elusive. BifA of Pseudomonas aeruginosa, for example, is another GGDEF-EAL 
protein that has been characterized as a phosphodiesterase as it suppresses biofilm formation. 
Interestingly, the biofilm reactions require both active site motifs as alanine substitutions in 
either the GGDEF (AAAAF) or EAL (AAL) fail to complement the biofilm defect of the 
∆bifA mutant. How the GGDEF domain is necessary has yet to be discovered (Kuchma et al., 
2007).  
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The biofilm-regulatory GGDEF-EAL protein MbaA 
One of these tandem GGDEF-EAL proteins is the biofilm regulator MbaA of V. 
cholerae. MbaA is bound to the membrane by two transmembrane regions with a periplasmic 
region between them. The GGDEF and EAL domains are within the cytoplasmic region. 
MbaA has previously been characterized as a phosphodiesterase (Bomchil et al., 2003, 
Cockerell et al., 2014). However, the function of the GGDEF domain has yet to be 
elucidated. The GGDEF domain has the potential of being an active diguanylate cyclase but 
could also play a regulatory role within MbaA. 
MbaA works within the NspS-MbaA signaling complex. NspS is a periplasmic 
protein that binds and responds to polyamines (Cockerell et al., 2014, Sobe et al., 2017). 
Polyamines are ubiquitous molecules made up of carbon chains with two or more amine 
groups (Karatan and Watnick 2009). NspS responds to three polyamines: norspermidine, 
spermidine, and spermine (McGinnis et al., 2009, Cockerell et al., 2014, Sobe et al., 2017). 
Norspermidine is found in the aquatic environment and enhances V. cholerae biofilm 
formation (Karatan et al., 2005). NspS is hypothesized to bind to norspermidine and then 
interact with the periplasmic region of MbaA and inhibit phosphodiesterase activity, allowing 
for the accumulation of c-di-GMP (Karatan et al., 2005, Cockerell et al., 2014). Spermine 
and spermidine are found in foodstuffs and produced by the human microbiome. It is 
hypothesized that when NspS senses spermine and spermidine V. cholerae reduces biofilm 
formation by inhibiting the interaction between NspS and MbaA (McGinnis et al., 2009, 
Sobe et al., 2017). If these hypotheses are true, these polyamines could be environmental 
signals that V. cholerae senses in order to recognize whether it is in a human host or in its 
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aquatic environment. When V. cholerae senses a change in environment, it would need to 
establish what state to be in: planktonic or biofilm (Karatan et al., 2005, Sobe et al., 2017). 
This NspS-MbaA signaling pathway may be a putative novel signaling pathway 
found in different bacteria. When a comparative genome analysis was conducted within 
sequenced bacterial genomes, it was revealed that 13 Proteobacteria species have periplasmic 
binding protein-encoding genes potentially co-transcribed with genes encoding MbaA-like 
tandem GGDEF-EAL proteins (Table 1) (Cockerell et al., 2014). This would indicate that 
characterizing the NspS-MbaA pathway may not only apply to Vibrio cholerae but yield 
insights into c-di-GMP signaling in many other bacteria.  
 
My research aims to better characterize the NspS/MbaA signaling pathway. The first 
step is to understand the role of the GGDEF domain in MbaA. This research is important to 
better understand how V. cholerae modifies its biofilm formation through the control of c-di-
GMP. If the GGDEF domain is a functional diguanylate cyclase, then the characterization of 
MbaA will give insight into the function of other dual function diguanylate cyclases 
phosphodiesterase enzymes within the bacterial world. If the GGDEF domain has a 
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regulatory effect on the EAL domain, this may shed light in how phosphodiesterase activity 
is controlled in other tandem GGDEF-EAL proteins. Both of these results would give insight 
into exploring the other 9 tandem GGDEF-EAL proteins found in V. cholerae and the 13 
other bacterial species with NspS-MbaA like protein pairs.  
Cholera takes 100,000 lives worldwide every year; it is of great importance to 
understand the life cycles of pathogenic bacteria in hopes of finding a key to treat or prevent 
infections. V. cholerae biofilms are believed to play a part in the pathogenesis of cholera; 
therefore, understanding how biofilms are regulated could give us clues to interrupt cholera 
pathogenesis. 
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Materials and Methods 
 
Bacterial strains and growth conditions 
E.coli and V. cholerae strains, plasmids, and primers used in this study are listed in 
Table 2 and Table 3, respectively. Primers were synthesized by Sigma-Aldrich (St. Louis, 
MO). Sequencing was performed by Eurofins (Louisville, KY). All strains were grown in 
Luria Bertani broth (LB) medium (per liter: 10 g tryptone, 5 g yeast extract, 10 g NaCl) with 
appropriate antibiotics. Sucrose agar (333.3 mL of DI water, 2.5 g of yeast extract, 2.5 g of 
tryptone, 7.5 g of agar, 30% sucrose) plates were used when mentioned. E. coli strains were 
incubated at 37°C and V. cholerae was incubated at 27°C, except V. cholerae strains 
containing pEVS143 or pMbaA, which were incubated at 37°C unless otherwise specified. 
Ampicillin, streptomycin, and kanamycin were used at a concentration of 100 µg/mL unless 
otherwise specified. 
Multiple Sequence Alignment of GGDEF-EAL proteins 
ScrC and DcpA are hypothesized dual functional diguanylate cyclase 
phosphodiesterases and were chosen as comparisons to MbaA amino acid sequence 
alignment (Ryjenkov et al., 2005, Ferreira et al., 2008, Feirer et al., 2015). Sequences were 
retrieved from the Integrated Microbial Genomes and Microbiomes database 
(https://img.jgi.doe.gov/): MbaA (Q9KU26), DcpA (NP_357114), and ScrC (AAK08640). 
These sequences were input into the Simple Modular Architecture Research Tool (SMART) 
(http://smart.embl-heidelberg.de/) to identify the GGDEF-EAL regions of the proteins. The 
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regions of the proteins containing only the GGDEF and EAL domains were then aligned 
using the multiple sequence alignment tool Clustal Omega 
(https://www.ebi.ac.uk/Tools/msa/clustalo/). 
Table 2. Bacterial strains and Plasmids used in this studya 
Strains or 
plasmids 
 
Description Source 
E. coli strains   
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) 
U169 recA1 endA1 hsdR17 (rK–, 
mK+) phoA supE44 λ– thi-1 gyrA96 
relA1 
Invitrogen 
NEB express fhuA2 [lon] ompT gal sulA11 R(mcr-
73::minutesiTn10--TetS)2 [dcm] R(zgb-
210::Tn10--TetS ) endA1 Δ(mcrC-
mrr)114::IS10 
New England Biolabs 
DH5α λ pir supE44 ΔlacU169 hsdR17, recA1 
endA1 gyrA96 thi-1 relA1, λpir 
(Hanahan, 1983) 
SM10 λpir thi thr leu tonA lacY supE recA∷RP4-
2-Tc∷MuλpirR6K; KmR 
(Moorthy & Watnick, 2005)  
AK730 DH5α with pWHIT1; ApR This study 
AK737 DH5α with pWHIT2; ApR This study 
AK747 DH5α with pWHIT3; ApR This study 
AK756 NEB express with pWHIT4; ApR This study 
AK805 DH5α with pWHIT5 This study 
AK338 NEBexpress with pRC2 (Cockerell et al. 2014) 
AK806 DH5α with pWHIT6 This study 
AK817 DH5α with pWHIT7 This study 
AK811 DH5α with pWHIT8 This study 
AK833 Sm10λpir with pWHIT7 This study 
AK842 Sm10λpir with pWHIT8 This study 
NEB α fhuA2 Δ(argF-lacZ)U169 phoA glnV44 
Φ80 Δ(lacZ)M15 gyrA96 recA1 relA1 
endA1 thi-1 hsdR17 
(Lee et al., 2015)  
AK856 NEB 5α with pWHIT9 This study 
AK868 NEB 5α with pWHIT10 This study 
 
 
V. cholerae 
strains 
  
PW357 MO10lacZ∷vpsLp→lacZ, SmR (Haugo & Watnick, 2002)  
AK839 PW357 ∆mbaA-GGDEF This study 
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Strains or 
plasmids 
 
Description Source 
V. cholerae 
strains 
  
AK845 PW357 ∆mbaA-EAL This study 
PW444 MO10lacZ∷vpsLp→lacZ ∆mbaA, SmR  (Bomchil et al., 2003)  
PW514 MO10lacZ∷vpsLp→lacZ ∆nspS, SmR (Karatan et al., 2005)  
AK555 PW444 with pMbaA, KmR (Sobe et al., 2017)  
AK865 PW444 with pWHIT9, KmR This study 
AK872 PW444 with pWHIT10, KmR This study 
AK564 
 
PW444 with pEVS143  
Plasmids   
pCR2.1-TOPO Plasmid for TOPO cloning, ApR Invitrogen 
pMAL-c5x malE encoded with in frame insertion 
of the C-terminutesus of domain; ApR 
New England Biolabs 
pWHIT1 pCR2.1-TOPO::Mba-GGDEF domain; 
ApR 
This study 
pWHIT2 pCR2.1-TOPO::Mba-EAL domain; 
ApR 
This study 
pWHIT3 pMAL-c5x::Mba-GGDEF domain; ApR This study 
pWHIT4 pMAL-c5x::Mba-EAL domain; ApR This study 
pWHIT5 pCR2.1-TOPO::MbaA∆EAL, ApR This study 
pWHIT6 pCR2.1-TOPO::MbaA∆GGDEF, ApR This study 
pWM91 oriR6k, lacAα, sacB, homologous 
recombination plasmid, ApR 
(Metcalf et al., 1996)  
pWHIT7 pWM91:: MbaA∆GGDEF, ApR This study 
pWHIT8 pWM91:: MbaA∆EAL, ApR This study 
pEVS143 KmR (Dunn et al., 2006)  
pMbaA pEVS143::VC0703, KmR (Massie et al., 2012)  
pWHIT9 pMbaA∆EAL, KmR This study 
pWHIT10 pMbaA∆GGDEF, KmR This study 
   
aAnibiotic resistance phenotypes: streptomycin, SmR; ampicillin, ApR; kanamycin, KmR 
 
 
Table 3. Primers used in this study* 
Primers Description Sequence (5’→3’) Source 
 
M13 
forward 
Used for sequencing 
insertion into pCR2.1-
TOPO and pMAL-c5x 
GTAAAACGACGG
CCAG 
(Messing, 1983) 
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Primers Description Sequence (5’→3’) Source 
 
M13 
Reverse 
Used for sequencing 
insertion into pCR2.1-
TOPO and pMAL-c5x 
CAGGAAACAGCT
ATGAC 
(Messing, 1983) 
    
PA323 Forward primer for the 
cloning of MbaA-
GGDEF in to pMAL-
c5x with a NdeI site 
CATATGGCCATGT
ACAGCGAACTTC  
 
This study 
PA324 Reverse primer for the 
cloning of MbaA-
GGDEF in to pMAL-
c5x with a BamHI site 
GGATCCCTAATA
GTAAGCGACTTG
GTT 
 
This study 
PA325 Forward primer for the 
cloning of MbaA-EAL 
in to pMAL-c5x 
CATATGCAGCGG
CGCAATAATATTG 
 
This study 
PA326 Reverse primer for the 
cloning of MbaA-EAL 
in to pMAL-c5x 
GGATCCCTAACG
GCATTCACTTTG 
 
This study 
PA335 Reverse primer for 
upstream of GGDEF 
deletion 
CGCAAGTGCTTTC
GTGCG  
This study 
PA336 Forward primer for 
upstream of GGDEF 
deletion 
CTCAGTTATAACC
GCCAAGACGTG  
This study 
PA337 Forward primer for 
downstream of 
GGDEF deletion with 
SOE tag 
CGCACGAAAGCA
CTTGCGGTCGCTT
ACTATTCGCAG  
This study 
PA338 Reverse primer for 
downstream of 
GGDEF deletion 
CGGCAAACGTTTC
GGTGA  
This study 
PA339 Reverse primer for 
upstream of EAL 
deletion 
ATTGCGCCGCTGT
ACTATTTG  
This study 
PA340 Forward primer for 
upstream of EAL 
deletion 
GATACTCAGCAT
ATCTGGGTCATG  
This study 
PA341 Forward primer for 
downstream of EAL 
deletion with SOE tag 
CAAATAGTACAG
CGGCGCAATTAG
AAGTGCCTTTAGC
ACCG  
This study 
PA342 Reverse primer for 
downstream of EAL 
deletion 
AGAGCGAGAATT
AAGGCCTGA  
This study 
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Primers Description Sequence (5’→3’) Source 
 
PA364 Reverse primer for 
amplification of the 
end region of MbaA 
CTAACGGCATTCA
CTTTGGCTGGG 
This study 
PA370 Forward primer for 
amplification of 
GGDEF deletion for 
use in Q5 mutagenesis 
kit 
TCGCAGGCGTTA
GATCAAATA 
This study 
PA371 Reverse primer for 
amplification of 
GGDEF deletion for 
use in Q5 mutagenesis 
kit 
TTCGCTGTACATG
GCGTA 
This study 
PA372 Forward primer for 
amplification of EAL 
deletion for use in Q5 
mutagenesis kit 
ATCTCCCCATGGC
TTCATG 
This study 
PA373 Reverse primer for 
amplification of EAL 
deletion for use in Q5 
mutagenesis kit 
GCGCCGCTGTACT
ATTTG 
This study 
*Restriction enzyme sites are underlined 
Cloning regions encoding the individual domains of MbaA into pMAL-c5x 
Primers were designed that flanked the regions of the gene encoding individual 
domains of MbaA. Domains were identified using SMART. PA323 and PA324 had a melting 
temperature of 66 °C and 67.5 °C, respectively. They were designed to amplify a 570 bp 
fragment that encoded amino acids 324 through 502 from the end of the transmembrane 
region to the beginning of the EAL domain, which would capture the GGDEF domain in its 
entirety.  PA325 and PA326 had a melting temperature of 64.6 °C and 67.6 °C, respectively. 
They were designed to amplify an 843 base pair fragment that encoded amino acids 515-756, 
from the end of the GGDEF domain to the end of MbaA, which encompasses the EAL 
domain. Restriction enzyme cut sites of BamHI and NdeI were introduced into the 5’ ends of 
the primers for later use. PCR was run using Q5 polymerase (New England Biolabs, Inc, 
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Ipswich, MA). Cycling conditions were as follows: initial denaturation at 98 °C for 30 
seconds; 35 cycles of denaturation at 98 °C for 10 seconds, annealing at 59 °C for 30 
seconds, and extension at 72 °C for 30 seconds; final extension of primers was set at 72 °C 
for two minutes. Adenines were added to 3’ blunt ends of the PCR products by following the 
manufacturer’s instructions: 10 µL of PCR product was mixed with 33.5 µL water, 5 µL 
OneTaq polymerase buffer, 1 µL dATP (10 mM), and 5 µL OneTaq polymerase and 
incubated at 72 °C for 10 minutes. This product was then cloned into the pCR2.1-TOPO 
vector (Invitrogen, Carlsbad, CA), which contains thymine overhangs on the linearized 
plasmid. This produced pWHIT1 and pWHIT2 for the GGDEF domain and EAL domain, 
respectively (Table 2). These plasmids were then electroporated into the Escherichia coli 
DH5α using a BIO-RAD MicroPulser (Hercules, CA) at 1.8 kV. The transformed DH5α was 
recovered with SOC media at 37 °C at 200 rpm for one hour. The cells were then plated onto 
LB agar with 100 µg/L amp and 40 µg/mL 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X Gal). Blue-white screening was conducted to find colonies containing 
plasmids with the cloned inserts. White colonies were chosen to use in a colony PCR. Single 
cells were suspended in 100 µL of water and then lysed at 95 °C for 5 minutes. Two µL of 
this lysate was then used as a template in a PCR reaction consisting of 16.4 µL water, 5 µL 
5X OneTaq Standard Reaction Buffer, 0.5 µL dNTPS, 0.5 µL of each 10mM forward and 
reverse primer, and 0.125 µL OneTaq Hot Start DNA polymerase (New England Biolabs, 
Inc, Ipswich, MA). Plasmids were extracted from three colonies containing the confirmed 
insert using a Wizard Plus SV Miniprep DNA Purification Kit (Promega, Madison, WI). The  
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Fig 2. Plasmid map of (a) pWHIT3 and (b) pWHIT4. (a) pWHIT3 and (b) pWHIT4 was 
constructed by digesting pMal-c5x and pWHIT2 and pWHIT1, respectively, with BamHI 
and NdeI and then ligating with Electroligase. Domains were designed to be in frame of the 
malE gene which encodes a maltose binding protein. 
 
plasmids were further confirmed by sequencing using forward and reverse M13 primers 
(Table 2). 
The plasmids pWHIT1 and pWHIT2 were then digested using BamHI and NdeI to 
release the insert. The expression plasmid pMAL-c5x (New England Biolabs, Inc), which 
encodes a maltose binding protein from E. coli, was also digested with the same enzymes and 
the insert was ligated into pMAL-c5x to form pWHIT3 and pWHIT4, respectively, using 
Electroligase (New England Biolabs, Inc.) (Fig. 2; Table 2). The product was designed so 
that the produced protein would be in frame with the encoded modified maltose binding 
protein (malE). This produces a fusion between the maltose binding protein and the protein 
domain of interest. The maltose binding protein has been modified to bind to amylose as a 
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way to purify the protein of interest. The plasmids pWHIT3 and pWHIT4 were 
electroporated into DH5α and recovered as previously described (Table 1). To confirm the 
insertion was present colony PCR was performed and plasmid was extracted as described 
above. The plasmid was then chemically transformed into NEB express (New England 
Biolabs, Inc) by incubating on ice for 15 minutes, then a 42 °C water bath for 65 seconds and 
then placed on ice for three minutes. Cells were recovered in LB media for one hour at 37 °C 
at 200 rpm. NEB express transformed with pWHIT3, which encoded the GGDEF domain, 
did not survive. Diguanylate cyclases have been documented to be lethal in some E. coli 
strains. Other studies have previously cloned diguanylate cyclases using the pMAL systems 
in DH5α; therefore, pWHIT3 was retained in DH5α while pWHIT4 was successfully 
transformed into NEB express (10). 
Expression and purification of MBP-GGDEF and MBP-EAL 
All proteins purified in this research had a pMAL backbone and were purified in the 
same way unless otherwise specified. The fusion proteins were expressed in their respective 
E. coli strain at 37°C for 17 hours 10 mL LB with 100 µg/mL ampicillin and 0.2% glucose; 
glucose inhibits amylase production which would degrade the amylose resin used during 
purification. MBP-Cterm is a fusion protein of maltose binding protein and the C terminus 
portion of MbaA containing both the GGDEF and EAL domains; this protein was used 
previously to characterize MbaA phosphodiesterase activity (Cockerell et al., 2014). Slr1143 
is a maltose binding protein fusion with the Synechocystis sp. PCC6803 protein Slr1143 
which has been characterized as an active diguanyalte cyclase (Ryjenkov et al., 2005). The 
10mL overnight cultures were then added to 1L cultures of LB with 100 µg/mL ampicillin 
and 0.2% glucose and E. coli cells were grown to an OD595 of 0.4 to 0.6. Expression was 
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induced with the addition of IPTG to the final concentration of 0.3 mM. Cells were grown 
overnight at respective temperatures with shaking at 200 rpm and then centrifuged at       
4,000 x g for 20 minutes at 4 °C. Cells expressing MBP-GGDEF, MBP-EAL, and Slr1143 
were incubated at 30°C while cells expressing MBP-Cterm was incubated at 18°C to 
decrease inclusion body formation. The cells were resuspended in 25 mL column buffer (200 
mM NaCl, 0.5 mM EDTA, 5 mM MgCl2, 20 mM Tris-HCl (pH 7.6)) and then frozen. The 
cells were thawed on ice and then sonicated for 15-second intervals for a total of 2 minutes. 
Lysates were then centrifuged at 20,000 x g for 20 minutes at 4°C to pellet cells. The cleared 
lysate was then transferred to a 50 mL conical tube and combined with the prepared amylose 
resin. One mL of amylose resin was prepared by resuspending the resin with column buffer 
and then centrifuged at 700 x g for 1 minutes, this process was repeated three times 
producing 500 µL of packed amylose resin. The amylose resin lysate mix was then incubated 
overnight at 4 °C with rotation. The protein was then washed with 50 mL of column buffer 
and then eluted four times with 1 mL of elution buffer (column buffer with 20mM maltose) 
using a gravity column. Ten µL of each fraction were run on a 10 % SDS-PAGE gel at 250 V 
for 45 minutes and stained with 0.01% coomasie brilliant blue. 
Phosphodiesterase and diguanylate cyclase assays 
Purified protein fractions were combined and were dialyzed into their respective 
reaction buffer using Slide-A-Lyzer dialysis cassettes (Pierce) two times for 4 to 16 hours at 
4 °C. MBP-EAL was dialyzed into a phosphodiesterase buffer (50mM Tris, adjusted to      
pH 8.5) and the MBP-GGDEF was dialyzed into diguanylate cyclase buffer (50 mM Tris-
HCl (pH 7.6), 10 mM MgCl2, 0.5 mM EDTA, and 50 mM NaCl). The protein was extracted 
from cassettes and concentration calculated using BSA standard curve; this BSA standard 
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curve was calculated separately with each buffer to provide accurate results. MnCl2 was 
added to the phosphodiesterase reaction after dialysis at a final concentration of 2mM. The 
reactions contained 2.5 µM of MBP-GGDEF and MBP-EAL and 2 μM of MBP-Cterm. The 
substrate was added at 100 µM to start the reaction. Phosphodiesterase reactions were 
incubated at 37 °C for 2 hours. Diguanylate cyclase were incubated at 37 °C for 5 hours. A 
time course phosphodiesterase assay was set up as previously described with MBP-EAL and 
MBP-Cterm for 0, 30, 60, and 120 minutes. Reactions were stopped by the addition of CaCl2 
at the final concentration of 10 mM. CaCl2 is a competitive inhibitor that prevents the 
binding of MnCl2, which stops phosphodiesterase reactions.  
HPLC analysis 
The enzymatic reactions were boiled for 5 minutes and then centrifuged at 14,000 x g 
for 7 minutes using a Nanosep 10 kDa Omega filter (Pall Life Sciences, Port Washington, 
NY) to remove proteins. Forty µL of the reaction products were separated using a 
SUPELCOSILTM LC-18 column (Sigma-Aldrich, St. Louis, MO) with a Waters 1525 Binary 
HPLC Pump and analyzed using a Waters 2487 Dual λ Absorbance detector (Milford, MA). 
Peaks were identified by comparison to purified GTP, c-di-GMP, and pGpG standards 
(Biolog Life Science Institute, Brememn, Germany; Jena Bioscience, Jena, Germany). The 
areas under the curves representing c-di-GMP and 5’ pGpG peaks were used to calculate 
product formation and was analyzed using Microsoft Excel (Redmond, WA). 
Deletions of the individual domains of MbaA on V. cholerae chromosome 
In order to characterize how these domains, regulate biofilm formation I decided to 
delete the individual domains from the chromosome. The strains carrying these domain 
deletions would then be used in a biofilm assay to see if these domains play a part in biofilm 
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formation. Primers with complementary regions were designed to flank regions of the mbaA 
gene encoding the GGDEF and EAL domains (Table 3). PA335 and PA336 had a melting 
temperature of 58 °C and 57.6 °C, respectively, and were designed to amplify 477 bp 
between the amino acids 180 and 333, spanning a portion of the transmembrane region 
before the GGDEF domain (Fig. 3). PA337 and PA338 had a melting temperature of 67.9 °C 
and 56.4 °C, respectively, and were designed to amplify 460 bp between the amino acids 498 
and 645, spanning a fragment of the EAL domain (Fig. 3). These two fragments were 
designed to flank the GGDEF domain (Fig. 3). PA339 and PA340 had a melting temperature 
of 56.1 °C and 54.8 °C, respectively, and were designed to amplify 463 bp region between 
the amino acids 360 and 512, spanning a portion upstream of the EAL domain (Fig. 4). 
PA341 and PA342 had a melting temperature of 66.6 °C and 55.8 °C and were designed to 
amplify 462 bp which is between 15 bp upstream of the stop codon of MbaA and 419 bp 
down stream of MbaA stop codon, spanning the last portion of MbaA and an area 
downstream (Fig. 4). These two fragments were designed to flank the EAL domain (Fig. 4). 
The resulting PCR products were joined together with the help of the complementary regions 
by overlap extension PCR. The resulting construct was TOPO cloned into pCR2.1-TOPO as 
described above (Table 2). Correct construction was confirmed by colony PCR and 
sequencing. The plasmid was then extracted and purified as previously described. The 
plasmid and the suicide vector pWM91 were digested using the restriction enzyme XhoI and 
SpeI. Enzymes were heat killed at 80°C for 20 minutes. Both digested insert and plasmid 
were gel purified using the Monarch Gel Purification Kit (New England Biolabs, Inc). For 
the EAL deletion, pWM91 was also dephosphorylated using Antarctic phosphatase (New 
England Biolabs, Inc) to prevent religation of the vector and facilitate ligation of the ∆EAL 
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insert. The digested and gel purified pWM91 was mixed with 2 µL of 10x Antarctic 
phosphatase buffer and 5 µL Antarctic phosphatase and incubated at 37°C for 30 minutes. 
Enzyme was heat killed at 80°C for 2 minutes. The plasmid was ligated and then 
electroporated into an E. coli DH5α λ pir. To verify insertion, colony PCR was performed as 
previously described. The plasmid was then isolated as previously described and 
electroporated into Sm10 λ pir. This strain was used for conjugation with V. cholerae to 
generate in-frame chromosomal deletions through a SacB counter-selectable mutagenesis 
procedure (Metcalf et al., 1996).  
 
Fig 3. Construction of conjugation plasmid for the deletion of the GGDEF domain within 
MbaA. Primers were designed to amplify a ~400 bp upstream and downstream of the 
GGDEF domain. The forward primer of the downstream region was designed to be 
complementary to the reverse primer of the upstream region. Using overlapping PCR, the 
downstream and upstream were combined. This was then TOPO cloned into pCR2.1-TOPO 
to produce pWHIT6. It was then ligated into pWM91 using XhoI and SpeI to produce 
pWHIT7. 
 
V. cholerae strain PW357 was used as a wild-type strain (Table 1). The respective E. coli 
SM10λpir strain was mated with PW357 (Table 2). Briefly, V. cholerae and E. coli were 
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grown on LB-Agar plates with antibiotics and half of the growth was then streaked onto 
selective media (LB media with 100µg/ml streptomycin and 50µg/ml ampicillin), resistant 
colonies were then purified by streaking again on the same selective media. The colonies 
were then streaked onto LB media with no antibiotics to facilitate an intrachromosomal 
recombination. Next, single colonies were streaked on sucrose agar plates. Sucrose resistant 
colonies were then patched for selection on two plates: one plate of streptomycin and another 
of streptomycin and 50 µg/mL ampicillin. Colonies sensitive to ampicillin were selected and 
analyzed using colony PCR to identify colonies with domain deletions. 
 
 
Fig 4. Construction of conjugation plasmid for the deletion of the EAL domain within MbaA. 
Primers were designed to amplify a ~400 bp upstream and downstream of the EAL domain. 
The forward primer of the downstream region was designed to be complementary to the 
reverse primer of the upstream region. Using overlapping PCR, the downstream and 
upstream were combined. This was then TOPO cloned into pCR2.1-TOPO to produce 
pWHIT5. It was then ligated into pWM91 using XhoI and SpeI to produce pWHIT8. 
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Deletion of regions encoding individual domains in pMbaA 
Because stability issues were a concern after chromosomal deletions and because 
native levels of MbaA are too low to review in a western blot, domain deletions were 
performed on a plasmid. The Q5 Site-Directed Mutagenesis Kit (New England Biolabs, Inc.) 
was used to create domain deletions of the plasmid pMbaA (Table 3). Primers were designed 
using NEBasechanger (New England Biolabs, Inc.) to amplify away from the domain of 
interest; this would lead to amplifying of the plasmid except for the domain of interest 
leading to a PCR product that includes the plasmid backbone and mbaA excluding a domain 
(Table 3; Fig. 5). Amplification using primers PA370 and PA371, which had a melting 
temperature of 64 °C resulted in deletion of amino acids 327 to 507 of MbaA. Amplification 
using primers PA372 and PA373, which had a melting temperature of 65 °C and 64 °C 
respectively, resulted in deletion of amino acids 518 to 760 of MbaA. Amplification was 
done using 12.5 µL 2x Q5 Master Mix (final concentration 1x), primers at final 
concentrations of 0.5 µM, and a pMbaA amount between 14 ng to 27.5 ng. PCR parameters 
were as follows:  initial denaturation 98°C for 30 second, 30 cycles of 98°C 10 second, 59°C 
30 second, 72°C 4 minutes, and a final extension of 72°C for 2 minutes. This PCR product 
was then used in a Kinase, Ligase, and DpnI (KLD) enzymes mix reaction (New England 
Biolabs, Inc.; Fig. 5). This mix is optimized to carry out multiple reactions in one tube. The 
kinase adds a phosphate group to the 5’ end of the amplicons, ligase ligates the completed 
PCR produce to circularize it and DpnI degrades the methylated template DNA (Fig. 4). The 
reaction contained 1 µL of PCR product, 5 µL 2x KLD reaction buffer (final concentration 
1x), and 1µL 10x KLD enzyme mix (final concentration 1x). For the EAL deletion, the 
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reaction was set to 5 minutes at 21°C. The GGDEF deletion was set to 5 minutes at 21°C and 
then 30 minutes at 37°C to increase DpnI activity as initial attempts to delete the domain 
using the first set of conditions were unsuccessful. Five microliters of the reaction were then 
added to chemically competent NEB 5α cells (Table 1) for 30 minutes on ice. Cells were then 
heat shocked for 30 seconds and then placed on ice for 3 minutes. Cells were recovered in 
SOC media at 37°C for one hour. They were then plated on LB agar plates with kanamycin 
and incubated overnight. Colony PCR was used to confirm deletions using primers PA336 
and PA364 (Table 2). These primers were also used to sequence the plasmids. 
 
Fig 5. Depiction of Q5 mutagenesis procedure. (a) Primers were designed to amplify away 
from the GGDEF domain. (b) Amplification produced amplicons missing the GGDEF 
domain. (c) Hypothesized amplicon. (d) The amplicon was then used in a KLD reaction 
where first a kinase phosphorylates the 5’ and 3’ ends of the amplicon. (E) A ligase joins the 
two ends to produce a plasmid. (f) DpnI digests the methylated template plasmid (methyl 
groups shown in light gray). (g) Final product is pWHIT10 to be transformed into NEB 5α. 
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Biofilm assays for in vivo analysis of domain functions 
A single colony was added to a 2 mL culture of LB with streptomycin and then 
allowed to grow for 17 hours (Table 2). A day culture was then set up with a 1:50 dilution of 
the original culture used to inoculate another 2 mL culture of LB with streptomycin and 
allowed to grow to an OD655 of 0.3-0.4. This was then normalized to an OD655 of 0.04 in a 
300 µL culture inside a borosilicate tube. The bacteria were incubated for 16 hours at 27 °C. 
After incubation, the planktonic cells were removed and 150 µL was measured at OD595 in a 
96-well microplate. The biofilm was then washed once with 300 µL of 1X phosphate-
buffered saline (PBS). The biofilm was then homogenized by vortexing with 1.00 mm glass 
beads (BioSpec, Bartlesville, OK) in 300 µL of 1X PBS; 150 µL of this homogenized mix 
was added to the microplate and measured using a BIO-RAD iMark MicroPlate Reader 
(Hercules, CA) at a wavelength of 595 nm. Biofilm assays were performed with three 
technical replicates each time and repeated three times for accuracy. Student’s t-tests were 
used to detect significant differences between various strains and treatments. 
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Results 
 
Sequence analysis of the domains in MbaA 
V. cholerae strictly regulates biofilm formation in response to environmental stimuli 
(Karatan & Watnick, 2009, Teschler et al., 2015). The NspS-MbaA signaling system is 
hypothesized to be a regulation system that controls biofilm formation in response to specific 
polyamines (Karatan et al., 2005, McGinnis et al., 2009, Sobe et al., 2017). The polyamines 
spermine and spermidine are sensed by NspS; this interaction is hypothesized to enhance the 
phosphodiesterase activity of MbaA which leads to a subsequent decrease in biofilm 
formation (McGinnis et al., 2009, Sobe et al., 2017). However, when NspS senses 
norspermidine, it is hypothesized to inhibit MbaA phosphodiesterase activity, allowing an 
accumulation of c-di-GMP, which enhances biofilm formation (Karatan et al., 2005). MbaA 
harbors both GGDEF and EAL domains. Two other proteins, ScrC and DcpA, also have 
tandem GGDEF-EAL domains and have both diguanylate cyclase and phosphodiesterase 
activities (Ferreira et al., 2008, Feirer et al., 2015). While BphG1 is a dual functional 
diguanylate cyclase phosphodiesterase, it can only have diguanylate cyclase activity when 
the EAL domain has been removed (Tarutina et al., 2006). Because BphG1 cannot function 
has a diguanylate cyclase in its complete form it was excluded from the alignment. This led 
me to hypothesize that MbaA is a dual-function enzyme with both diguanylate cyclase and 
phosphodiesterase activities. This would suggest that when NspS senses norspermidine it not 
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only inhibits phosphodiesterase activity, but possibly activates diguanylate cyclase activity, 
leading to increased c-di-GMP concentration in the cell. 
To exhibit both activities, MbaA must have the catalytic amino acids necessary for 
both diguanylate cyclase and phosphodiesterase activity and have the flexibility to 
accommodate both activities. To determine whether MbaA had the conserved catalytic 
residues required for both activities, a multiple sequence alignment was done to compare the 
protein sequences of MbaA, DcpA, and ScrC (Fig. 6). I only analyzed the GGDEF-EAL 
portions of the proteins to ensure the best alignment (Fig. 6).  
I wanted to first confirm that MbaA had all the catalytic amino acids necessary for 
phosphodiesterase activity. I located the catalytic amino acids first characterized in RocR of 
P. aeruginosa: Q161, E175, A176, L177, R179, E265, N233, D295, D296, and D318 (Rao et 
al., 2008). I was able to identify all these catalytic amino acids within DcpA, ScrC, and 
MbaA. MbaA has the amino acids Q539 (RocR Q161), R558 (RocR R179), D673 (RocR 
D296), and D695 (RocR D318), which are required for interactions with the c-di-GMP 
molecule (Fig. 6) (Rao et al., 2008). The amino acids that coordinate either the Mg2+ and 
Mn2+ ions were also identified in MbaA: E554 (RocR E175), N612 (RocR N233), D672 
(RocR D295), E644 (RocR E265) (Fig. 6). The H2O molecule would be coordinated by 
MbaA E727 (RocR E352) (Fig. 6). Without coordinating the metal ion and H2O, there would 
be no nucleophilic attack on a phosphorous of c-di-GMP and it would not produce 5’ pGpG. 
MbaA also had the amino acids V555 (RocR A176) and L556 (RocR L177), which stabilizes 
these proteins (Fig. 6) (Rao et al., 2008). The valine to alanine substitution seen in Mba 
position V555 is a conserved substitution and seen in other phosphodiesterases  
(Kazmierczak et al., 2006). Conservation of the amino acid residues required for 
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phosphodiesterase activity confirms that MbaA was correctly characterized as a 
phosphodiesterase. 
I then analyzed if the GGDEF domain of MbaA had the potential to be a diguanylate 
cyclase. I used the catalytic amino acids first described in the characterized C. crescentus 
diguanylate cyclase PleD: R300, D327, N335, D344, G368, G369, E370, E371, F372, K442, 
R446 (Chan et al., 2004). I then identified these in DcpA, ScrC, and MbaA. MbaA had the 
two amino acids necessary to bind GTP: N384 (PleD N335) and D393 (PleD D344) (Fig. 6). 
The magnesium ion would be coordinated by D376 (PleD D327), D426 (PleD E370), and 
E427 (PleD E371) (Fig. 6). The substitution of the aspartate (PleD E370) to glutamate 
(MbaA E427) within the GGDEF motif is a well-known substitution in diguanylate cyclases 
and should not affect activity (Whiteley & Lee, 2015). The intermediate formed in this 
reaction is stabilized by K496 (PleD K442) and K501 (PleD R446). The substitution of an 
arginine (PleD R446) to a lysine (MbaA K501) is a conserved substitution as both amino 
acids are basic; however, DcpA has a substitution of a proline (P) which is not a conserved 
substitution, this may indicate that this amino acid is not completely necessary for 
diguanylate cyclase activity (Fig. 6). The conserved sequence of GGDEF in MbaA is SGDEF 
(S424-G425-D426-E427-F428) (Fig. 6). The GTP in PleD is oriented to cover the conserved 
glycines; however, in MbaA the first glycine is substituted with a serine (Fig. 6). This was 
thought to produce an inactive GGDEF domain, but the P. atrosepticum ECA372 diguanylate 
cyclase also has a SGDEF domain which means a glycine to serine substitution within the 
GTP binding site can be accommodated by the enzyme (Pérez-Mendoza et al., 2011). 
Therefore, this substitution does not rule out diguanylate cyclase activity. In the alignment, 
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MbaA is the only protein to have a seven amino acid insertion seven amino acids upstream of 
the GGDEF site. How this insertion affects MbaA activity is not known. 
 
Fig 6. Multiple sequence alignment of MbaA, DcpA, and ScrC. The C-terminus sequences 
containing the GGDEF-EAL domains of MbaA, DcpA, and ScrC were aligned using Clustal 
Omega. The catalytic amino acids for diguanylate cyclase acitivity and phosphodiesterase 
activity were highlighted in grey. The amino acids between these domains are underlined in 
black. The seven amino acid insertion in MbaA is outlined in black. 
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There are several amino acids that link the GGDEF domain and EAL domain 
together. This linker is thought to be long enough to provide the protein with flexibility to  
accommodate both activities. I looked at the amino acids between these two domains to see if 
MbaA had similar number of amino acids as DcpA and ScrC. ScrC has 10 amino acids 
between its GGDEF and EAL domains and DcpA and MbaA have 9 (Fig. 6). Since MbaA 
has a similar number of amino acids between GGDEF and EAL to the other dual functional 
enzymes it is plausible that MbaA has enough structural flexibility to accommodate dual 
activities. 
The GGDEF domain of MbaA does not have diguanylate cyclase activity in vitro 
Because the multiple sequence alignment did not allow us to reject the hypothesis that 
the GGDEF domain could be a diguanylate cyclase, I wanted to test the GGDEF domain of 
MbaA for in vitro diguanylate cyclase activity. I designed primers to amplify the GGDEF 
domain of MbaA from chromosomal DNA (PW249) (Waldor & Mekalanos, 1994). This 
amplification produced a PCR product of approximately 0.5 kbp with some nonspecific 
amplification products of 0.4 kbp and 0.1 kbp (Fig. 7a). This product was gel purified and 
then cloned into pCR2.1 to produce pWHIT1. pWHIT1 was then sent out for sequencing to 
confirm correct sequence. The insert was then cloned into pMAL-c5x to produce pWHIT3. 
This plasmid was transformed into E. coli DH5α.  Successful transformation was confirmed 
by colony PCR and the identification of an amplicon around 0.5 kbp (Fig. 7b). In colonies 1-
4 a roughly 0.5 kpb insert can be seen confirming that the plasmid was successfully 
transformed into DH5α (Fig. 7b). For maximal expression of MBP-GGDEF, pWHIT3 was 
supposed to be transformed into NEB express E. coli; however, no transformants were 
obtained. It has been reported that diguanylate cyclases can be lethal to some strains of E. 
 
34 
 
coli, specifically BL21 derivatives, which is the type of strain NEB express was derived 
from. I, therefore, chose to express MBP-GGDEF in DH5α.   
This protein was produced in 1 L cultures and purified using an affinity column with 
amylose-resin (Fig. 8). The maltose binding protein encoded in pMAL-c5x had been 
modified to bind to amylose. The fusion protein binds to amylose resin which allows 
contaminating proteins to be washed away as seen in the unbound fraction (UF) and wash 
(W) (Fig. 8). MBP-GGDEF was then eluted using 20 mM maltose which is seen in lanes 1-4 
(Fig. 8).  
 
Fig 7. Construction of pWHIT3. (a) Amplification of the GGDEF domain from chromosomal 
DNA. The GGDEF amplicon was approximately 0.5 kbps based on size marker (SM). (b) 
Colony PCR of pWHIT3 within DH5α.  
 
Maltose outcompetes amylose for binding to the maltose binding protein which allows the 
MBP fusion protein to be eluted (Fig. 8).  The MBP-GGDEF protein is approximately 60 
kDa. After the protein was confirmed to be eluted by SDS gel, fractions 1-4 were pooled, and 
then dialyzed into diguanylate cyclase reaction buffer (Fig. 8). 
A diguanylate cyclase assay was set up as described in the methods and the products 
were then separated using HPLC. The peaks of the chromatograms were compared to GDP, 
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Fig 8. Purification of MBP-GGDEF. Lysate (L) from IPTG induced MBP-GGDEF in DH5α 
was collected before binding with maltose resin. The unbound fraction (UF) wash (W) step, 
and purified products (1-4) following elution with maltose. B is protein left on the beads. The 
arrow denotes MBP-GGDEF. (SM is the size marker). 
 
GTP and c-di-GMP standards (Fig. 9a). The positive control, Slr1143, revealed two peaks; 
one peak at 9 min whose identity is unknown, and the peak at 17 min corresponding c-di-
GMP (Fig. 9b). The MBP-GGDEF chromatogram, however, had one peak at 15 min 
corresponding to GTP (Fig. 9c). Since no c-di-GMP peak was produced, MBP-GGDEF is not 
a diguanylate cyclase under these conditions. The lack of diguanylate cyclase activity in vitro 
led me to think that the GGDEF may play a regulatory role in MbaA phosphodiesterase 
activity. 
The EAL domain is functional independent of the GGDEF domain 
Tandem GGDEF-EAL proteins are not uncommon proteins within bacterial species. Vibrio 
cholerae has 10 tandem GGDEF-EAL proteins out of the 62 c-di-GMP-associated proteins in 
its genome. Several proteins with tandem GGDEF-EAL proteins within other bacterial  
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Fig 9. Chromatograms of (a) GDP, GTP, and C-di-GMP standards and the products of 
diguanylate cyclases assays for (b) Slr1143 and (c) MBP-GGDEF. (a) 100 μM GDP, GTP, 
and c-di-GMP standards. (b Slr1143; c MBP-GGDEF) Diguanylate cyclase assays were run 
with 2.5 μM enzyme and 100 mM GTP.  
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species have been characterized (Christen et al., 2005, Kazmierczak et al., 2006, Kuchma et 
al., 2007). In those proteins that have an active phosphodiesterase activity but no active 
diguanylate cyclase activity, the GGDEF domain was shown to have a regulatory role 
(Christen et al., 2005). So, my next hypothesis was that the GGDEF domain has a regulatory 
role within MbaA. For example, it may be possible that the GGDEF domain provides 
stability or another function that is necessary for phosphodiesterase activity to occur. If this 
were true, the EAL domain without the GGDEF domain would be nonfunctional and not be 
unable to linearize c-di-GMP. In order to establish if the GGDEF domain had a role in 
phosphodiesterase activity I produced a fusion protein of MBP-EAL and assayed its activity. 
 
 
Fig 10. Construction of pWHIT4. (a) Amplification of the EAL domain from chromosomal 
DNA. The GGDEF amplicon was approximately 0.5 kbps based on size marker (SM). (b) 
Colony PCR of pWHIT4 within NEB express.  
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Fig 11. Purification of MBP-GGDEF. Lysate (L) from IPTG induced MBP-EAL in NEB 
Express was collected before binding with maltose resin. The unbound fraction (UF) wash 
(W) step, and purified products (1-4) following elution with maltose. B is protein left on the 
beads. The arrow denotes MBP-EAL. (SM is the size marker). 
 
The sequence encoding the EAL domain of MbaA was amplified from chromosomal 
DNA to produce a PCR product of approximately 0.8 kbp (Fig. 10a). This product was 
cloned to produce pWHIT2 and confirmed by sequencing. The insert was then cloned into 
pMAL-c5x to produce pWHIT3. This plasmid was transformed into E. coli DH5α and then 
again into NEB express for maximal expression. The plasmid was confirmed in NEB express 
by colony  
PCR to identify an amplicon of 0.8 kbp (Fig. 10b). The plasmid pWHIT2 was used as a 
positive control and successfully identified a 0.8 kbp amplicon. pMAL-c5x was used as a  
negative control and no amplicon was seen (Fig. 10b). Colonies 1-5 were screened; only 
colony 1 had an amplicon of 0.8 kbp (Fig. 10b). 
 
39 
 
Protein expression and purification was done with MBP-EAL and MBP-Cterm as 
described in the methods. MBP-Cterm is the fusion protein of maltose binding protein joined 
with the MbaA C-terminus containing both GGDEF and EAL domains. This fusion protein 
has been previously used to characterize MbaA as a phosphodiesterase and was used as a 
positive control in this study (Cockerell et al., 2014). MBP-EAL was approximately 80 kDa 
(Fig. 11). The peaks in the chromatograms were then compared to standard peaks of 5’ pGpG 
and c-di-GMP. The positive control, MBP-Cterm, had two peaks at 15 min and 17.5 min, 
which correspond to 5’pGpG and c-di-GMP, respectively (Fig. 12a). The HPLC 
chromatogram of MBP-EAL, however, had only one peak at 15 min, having only 5’ pGpG 
detectable (Fig. 12b). MBP-EAL had a 100% conversion of c-di-GMP to 5’ pGpG. MBP-
Cterm in contrast had only 20% conversion of 5’pGpG from c-di-GMP. Within the same 
time frame, MBP-EAL had a higher output of 5’ pGpG than MBP-Cterm indicating that 
MBP-EAL has a higher rate of product formation. 
Because MBP-EAL seemed to produce more 5’pGpG in the same time frame, an 
assay was done to compare reaction rates. MBP-EAL and MBP-Cterm were incubated for 0, 
30, 60, and 120 min and products were assayed as described above (Fig. 13). By 120 min 
MBP-EAL had converted all 100 µM of c-di-GMP to 5’ pGpG, while MBP-Cterm had only 
converted roughly 20% of the c-di-GMP to 5’ pGpG (Fig. 13). This time course confirmed 
that MBP-EAL produced 5’pGpG in a faster rate than MBP-Cterm. This indicates that the 
GGDEF domain is inhibitory to phosphodiesterase activity. 
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Fig 12. Chromatograms of phosphodiesterase assay products of (a) MBP-Cterm and (b) 
MBP-EAL. Phosphodiesterase assays were run with 2.0 μM or 2.5 μM enzyme for Cterm 
and EAL, respectively, and 100 µM c-di-GMP.  
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Fig 13. Time course shown percent 5’ pGpG produced by MBP-Cterm and MBP-EAL. 
Phosphodiesterase assays were run with 2.0 μM and 2.5 μM enzyme for Cterm  (●)  and EAL 
(○), respectively, and 100 µM c-di-GMP. Reactions were incubated for 0, 30, 60, and 120 
minutes. The percent 5’ pGpG produced vs time. 
 
Role of GGDEF and EAL domains of MbaA in vivo 
C-di-GMP concentration within the cell is highly regulated by different proteins and 
factors (Conner et al., 2017). The in vitro data describe above have been collected in the 
absence of these native regulation systems. In vitro, the MbaA GGDEF domain has no 
activity and is inhibitory to the EAL domain. To determine whether in vitro results could be 
replicated in vivo, I performed domain deletions within the chromosome of V. cholerae. 
These mutations were designed to delete the various domains by homologous recombination. 
The GGDEF domain was deleted to see if its absence would disrupt MbaA 
phosphodiesterase activity in vitro. The EAL domain was deleted in order to see if the 
GGDEF domain may play a role in biofilm formation. A biofilm assay was then used to 
determine activity of the domains. Wildtype and ∆mbaA were used as comparisons for the 
mutants (Fig. 14). Biofilm formation exhibited by ΔmbaA, MbaAΔGGDEF, and MbaAΔEAL 
strains were significantly higher than the biofilm formation of wild-type MbaA. However, 
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biofilm formation exhibited by the MbaAΔGGDEF and MbaAΔEAL strains were not 
significantly different than biofilm formation by the ΔmbaA strain. These results were not 
expected as in vitro analysis did not show that the GGDEF domain was necessary for 
phosphodiesterase activity. The expected result would be that the GGDEF domain deletion 
would have diminished biofilms as phosphodiesterase activity would be increased (Fig. 14b). 
The high biofilms seen in the MbaAΔEAL strain were expected as without the EAL 
domain’s phosphodiesterase activity MbaA would be unable to deplete the c-di-GMP 
concentration in the cell (Fig. 14b). 
The deletion of the GGDEF domain did not support my in vitro results as biofilm 
formation was the same as the mbaA deletion strain. This could suggest that native regulatory 
elements play a part in biofilm formation that was not testable in vitro. However, it could 
also be that the domain deletions in vivo made the mutant protein unstable which hindered its 
expression. To test this, a Western Blot was performed to confirm proper expression of 
MbaA. I was unable to see expression, indicating that native levels of MbaA are too low to 
be analyzed using this method (Bond, unpublished results). To be able to detect MbaA, an 
overexpression plasmid, pMbaA, was used to generate the domain deletions as described in 
the Materials and Methods (Massie et al., 2012). These modified plasmids were then 
transformed into the ∆mbaA background to produce the strains, ∆mbaA with pMbaA∆EAL 
and ∆mbaA with pMbaA∆GGDEF. pMbaA has a pEVS143 backbone so pEVS143 was used 
as a vector control (Massie et al., 2012). Biofilm assays were conducted on ∆mbaA with 
pEVS143, ∆mbaA with pMbaA, ∆mbaA with pMbaA∆EAL, and ∆mbaA with 
pMbaA∆GGDEF (Fig. 15). The biofilm formed from strain ΔmbaA with pEVS143 was not 
significantly different than ∆mbaA pMbaA∆EAL, though it was significantly different than 
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pMbaA∆GGDEF  (p-value 5.8 E-10). ∆mbaA pMbaA was significantly different than ∆mbaA 
pMbaA∆EAL (p-value 3.8 E-16), but not significantly different than ∆mbaA pMbaA∆GGDEF 
(Fig. 15). The increase in biofilm formation in ∆mbaA pMbaA∆EAL is due to the lack of 
phosphodiesterase and was seen in chromosomal domain deletions as well. The ∆mbaA 
pMbaA∆GGDEF strain had a decrease in biofilm comparable to the overexpression strain 
indicating that the GGDEF domain is not necessary for phosphodiesterase activity. 
 Plasmid based domain deletions were produced in order to confirm stability of these 
proteins. Western blots are currently under way to confirm that these domain deletion 
proteins are being expressed and that they are being expressed comparatively to full length 
MbaA encoded in pMbaA.  
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Fig 14. Biofilm formation in chromosomal domain deletions. (a) Biofilms were formed in 
borosilicate tubes in LB broth for 18 h at 27°C and quantified as described in Materials and 
Methods. Error bars show standard deviations of three biological replicates. A star indicates a 
significant difference between wild-type and mutants. Bars are a comparison between ΔmbaA 
and MbaAΔGGDEF and MbaAΔEAL which was not significant. A p-value of ≤ 0.05 was 
considered significant. WT, wild type. (b) Expected results of the biofilms performed.  
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Fig 15. Biofilm formation plasmid based domain deletions. Biofilms were formed in 
borosilicate tubes in LB broth for 18 h at 37°C and quantified as described in Materials and 
Methods. Error bars show standard deviation of three biological replicates. One star indicates 
a statistical difference between ΔmbaA pEVS143 and ΔmbaA pMbaAΔGGDEF. Two stars 
indicate a statistical difference between ΔmbaA pMbaA and ΔmbaA pMbaAΔEAL. A p-value 
of ≤ 0.05 was considered significant. WT, wild type. 
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Discussion 
 
V. cholerae is able to switch between a biofilm state and a motile, planktonic state in 
accordance with environmental signals. These environmental signals are then transduced into 
the cytoplasm where c-di-GMP concentration is controlled. An abundance of c-di-GMP 
enhances biofilm formation, while its degradation enhances motility. The NspS-MbaA 
signaling system is hypothesized to control c-di-GMP levels by sensing environmental 
polyamines. NspS binds to three polyamines: spermine, spermidine, and norspermidine. 
When NspS binds to spermine and spermidine it is hypothesized to cause MbaA to increase 
phosphodiesterase activity, decreasing c-di-GMP in the cell. When NspS binds to 
norspermidine, it is hypothesized that NspS inhibits MbaA phosphodiesterase activity within 
the cell, leading to an accumulation of c-di-GMP. MbaA is a tandem GGDEF-EAL protein. 
While the phosphodiesterase activity of MbaA has been linked with its EAL domain, my 
research set out to determine the function of the GGDEF domain (Cockerell et al., 2014). I 
hypothesized that the GGDEF domain acted as a diguanylate cyclase when 
phosphodiesterase activity was inhibited. 
MbaA has the potential to be a dual functional diguanylate cyclase phosphodiesterase 
To first determine if this dual activity was possible, I performed an amino acid 
sequence alignment of the GGDEF-EAL domains between MbaA, DcpA, and ScrC. DcpA 
and ScrC are both dual functional diguanylate cyclase phosphodiesterases. I determined 
MbaA had the same catalytic amino acids necessary for both activities, as well as if MbaA 
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had the structural flexibility to accommodate both activities. The MbaA amino acid sequence 
retains all the catalytic amino acids necessary for both phosphodiesterase activity and 
diguanylate cyclase activity. MbaA also shares a similar number of amino acids between the 
two domains as ScrC and DcpA, indicating that the flexibility of the protein should be able to 
accommodate both enzymatic activities. However, MbaA also has a seven amino acid 
insertion seven amino acids upstream of the GGDEF motif. This insertion was not seen in 
either of ScrC and DcpA. How it affects the activity or protein structure of MbaA is not 
known. 
MbaA does not have diguanylate cyclase activity in vitro 
Because the MbaA had the potential for diguanylate cyclase activity I set out to 
determine if the GGDEF domain was a diguanylate cyclase in vitro. I did this by designing a 
fusion protein within the pMAL-c5x system. I cloned the GGDEF domain in frame with a 
maltose binding protein to produce MBP-GGDEF. This allowed me to be able to purify the 
MBP-GGDEF protein and perform a diguanylate cyclase assay with the fusion protein. I also 
purified a characterized diguanylate cyclase, Slr1143, and used it as a positive control in the 
same assay (Ryjenkov et al., 2005). Slr1143 was able to convert all the GTP into c-di-GMP 
within 5 hours. MBP-GGDEF, however, did not produce any products after a 5-hour 
incubation with GTP at 37 °C. Diguanylate cyclases form c-di-GMP by binding to GTP and 
then dimerizing in an antiparallel fashion (Chan et al., 2004, Ryjenkov et al., 2005). It is 
possible that the MBP fusion to the GGDEF domain may be inhibiting dimerization. 
Cleaving the maltose binding protein from the MBP-GGDEF protein is possible; however, 
maltose binding protein can provide increased solubility to the protein so cleaving the MBP-
GGDEF protein may cause the GGDEF domain to misfold and fall out of solution (Kapust & 
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Waugh, 1999).  It is important to note that the positive control used for the diguanylate 
cyclase assay in this study, Slr1143, is also an MBP fusion. The possibility of the MBP 
preventing dimerization has already been analyzed. When first analyzing MBP diguanylate 
cyclase fusion proteins researchers added a coiled-coiled domain (CC), which enhance 
dimerization, to Slr1143 and analyzed formation of c-di-GMP. They found that c-di-GMP 
formation was not impacted by addition of CC domain indicating that the Slr1143 GGDEF 
domain alone was able to dimerize with MBP (Ryjenkov et al., 2005). This data provides 
evidence that the lack of c-di-GMP formation was not due to an inhibition of dimerization 
but due to MBP-GGDEF not acting as a diguanylate cyclase in these conditions.  
MbaA phosphodiesterase activity is independent of the GGDEF domain 
Because the MBP-GGDEF protein was not an active diguanylate cyclase, I 
hypothesized that the GGDEF domain might play a role in the regulation of 
phosphodiesterase activity. To determine if the phosphodiesterase activity was affected by 
the GGDEF domain, I generated a MBP-EAL fusion protein. I also purified the previously 
characterized MBP-Cterm which is a fusion protein that has both the GGDEF and EAL 
domains of MbaA in frame with MBP (Cockerell et al., 2014). I used MBP-Cterm as a 
positive control as well as a comparison for rate of phosphodiesterase activity. MBP-EAL 
protein converted 100 µM c-di-GMP completely into 5’ pGpG, while MBP-Cterm was only 
able to convert 20 % of c-di-GMP to 5’ pGpG in the same time frame. This indicated that the 
GGDEF domain is inhibitory. To confirm this, a time course assay was set up to determine 
how fast product formation took place with each of the two proteins. Reactions were set up 
for 0, 30, 60, and 120 minutes. MBP-EAL domain steadily created 5’ pGpG, with the first 
formation of 5’ pGpG seen at 30 minutes and c-di-GMP completely converted into 5’ pGpG 
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at 120 minutes. MBP-Cterm, on the other hand, did not start 5’ pGpG formation until 60 
minutes and had only 20 % converted at 120 minutes. This confirms the results of the single 
time point phosphodiesterase assays and indicates that the GGDEF domain has an inhibitory 
effect on the phosphodiesterase activity under these conditions. 
How the GGDEF domain inhibits phosphodiesterase activity in MbaA is not 
completely known at this time. The GGDEF domain of MbaA could be controlling the rate of 
phosphodiesterase activity to slow c-di-GMP degradation to prevent stressful conditions. 
Degrading c-di-GMP too fast may cause V. cholerae to disperse out of the biofilm or remain 
in a planktonic state when environmental conditions would be detrimental to the bacteria. A 
similar hypothesis has been assessed for why diguanylate cyclases in V. cholerae have 
different rates of biofilm formation (Massie et al., 2012). 
There is also the possibility of the GGDEF domain of MbaA acting as an allosteric 
inhibitor. Allosteric activation has been seen in the phosphodiesterase CC3396, a tandem 
GGDEF-EAL protein in C. crescentus. This protein is similar to MbaA in that the GGDEF 
domain of CC3396 is very close in amino acid sequence to active diguanylate cyclases. 
CC3396 has the motif GEDEF, rather than the characterized GGDEF motif and is unable to 
produce c-di-GMP; however, it can still bind GTP. When GTP is bound to CC3396 it further 
activates phosphodiesterase activity (Christen et al., 2005). A similar regulation may be in 
place for MbaA where the GGDEF domain binds to a molecule, which causes inhibition of 
phosphodiesterase activity. The MbaA GGDEF domain has all the necessary catalytic amino 
acids for GTP binding; therefore, it may be able to bind to GTP or a similar molecule to 
inhibit the phosphodiesterase activity. The seven amino acid insertion seen in the GGDEF 
domain of MbaA may also modify the protein structure to bind to other molecules such as 
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GTP, ATP, or c-di-GMP. More research will have to be done if the GGDEF domain of 
MbaA is able to bind other molecules. 
In vitro analysis is optimal for analyzing catalytic activity because it enables a clear 
analysis of activity; however, when isolating the protein, factors within the cell that may 
affect protein activity are also removed. To see if my in vitro data would remain consistent 
when MbaA activity was analyzed in its native system, in vivo domain deletions were 
constructed in the chromosome by homologous recombination. Since MbaA is a biofilm 
regulator, the effects of the GGDEF and EAL domain deletion within MbaA were analyzed 
using biofilm assays. Both the MbaAΔGGDEF and MbaAΔEAL strains showed increased 
biofilm formation similar to a ΔmbaA mutant. This was not as expected as I had 
hypothesized that MbaAΔGGDEF would have lower biofilm than wild-type since the 
GGDEF domain was inhibitory in vitro. The increase in biofilm seen in the MbaAΔGGDEF 
mutants indicates that within a native system MbaA phosphodiesterase activity requires the 
GGDEF domain. However, it also could be that the domain deletions affected the stability of 
the protein which caused the protein to be degraded. I tried to ensure that mbaA mutants were 
being expressed through western blot analysis; however, I was not able to detect native levels 
of MbaA in the cell. To overcome this issue, an overexpression plasmid, pMbaA, was used. 
Domain deletions were constructed within pMbaA to produce pMbaAΔGGDEF and 
pMbaAΔEAL. Biofilm assays were then conducted with strains expressing these altered 
proteins. pMbaAΔEAL strain showed an increase in biofilm formation since without the 
EAL domain, MbaA is unable to break down c-di-GMP. pMbaAΔGGDEF had very little 
biofilm formation, which is similar to pMbaA background. Minimal biofilm formation is 
indicative to decreased c-di-GMP concentration which indicates that pMbaAΔGGDEF is a 
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functional phosphodiesterase. This result confirms that the GGDEF domain is not necessary 
for phosphodiesterase activity. I failed to support my hypothesis that the GGDEF domain is 
inhibitory as pMbaAΔGGDEF was not statistically different than pMbaA. It is possible that 
the overexpression of MbaA is causing there to be more MbaA to degrade c-di-GMP, 
causing an artificially low biofilm formation. Without chromosomal mutants the inhibition 
caused by GGDEF domain in MbaA cannot be confirmed. 
Future Directions 
In this work, I have showed that the GGDEF domain is not necessary for 
phosphodiesterase activity of MbaA and that it has an inhibitory effect on phosphodiesterase 
activity in vitro. However, how and why the GGDEF domain inhibits phosphodiesterase 
activity still needs to be determined. A number of experiments can be done as the next steps 
to characterizing the domains of MbaA. First, point mutations within the GGDEF motif may 
shed some light into how the GGDEF domain is inhibiting the phosphodiesterase activity. 
The most common point mutation in GGDEF proteins is a glutamate to alanine substitution 
to produce a GGDAF motif. This abolishes the coordination of the magnesium ion and 
prevents diguanylate cyclase activity. However, MbaA does not have diguanylate cyclase 
activity; therefore, it is unclear if alteration of the glutamate to alanine in the GGDEF motif 
would have an effect on the phosphodiesterase activity as coordination of the magnesium ion 
is unlikely to have an effect as the binding of the domain to an allosteric inhibitor. If this 
mutation does not increase phosphodiesterase activity, other molecules, such as GTP, ATP, 
and c-di-GMP, would have to be substituted to examine if they are necessary for binding to 
an allosteric inhibitor. If the GGDEF domain is binding to an allosteric inhibitor, point 
mutations may be able to cause the same increase in phosphodiesterase activity as seen in the 
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in vitro assay of MBP-EAL. These point mutations would have to be constructed on the 
chromosomal copy of mbaA since the overexpression of MbaA prevented me from seeing a 
difference in biofilm formation of ΔmbaA with pMbaA and ΔmbaA with pMbaAΔGGDEF. If 
point mutations on the chromosome show a decrease in biofilm formation, indicative of 
increased phosphodiesterase activity, the next step would be to analyze what molecule is 
binding to the GGDEF domain of MbaA.  
Molecules, such as GTP or ATP, could be added to the MBP-Cterm 
phosphodiesterase assay to see if they can replicate the phosphodiesterase rate seen in MBP-
EAL. GTP was found to activate phosphodiesterase activity of CC3396 in C. crescentus but 
may inhibit MbaA phosphodiesterase activity. There is also a possibility the GGDEF domain 
of MbaA may bind to ATP as GGDEF domains are homologs to adenyl cyclases (Pei & 
Grishin, 2001). A modified GGDEF domain in YybT of Bacillus subtilis was found to be an 
ATPase, so GGDEF domains have the potential of binding to ATP (Rao et al., 2010). Other 
molecules, such as other nucleotides, may be allosteric inhibitors as well, but further in vitro 
testing would have to be done to investigate this possibility. After the allosteric inhibitor is 
identified then point mutations from in vivo analysis could be applied to MBP-Cterm to see if 
these prevent binding to the inhibitor.  
There is also the potential that the GGDEF domain plays a role in the NspS-MbaA 
signaling system. The GGDEF domain may provide flexibility to MbaA such that when 
NspS interacts with MbaA it could change the protein confirmation, causing the GGDEF 
domain to prevent the EAL domain from being able to cleave c-di-GMP. The Karatan lab is 
currently working on a method to analyze the NspS-MbaA interaction in vitro. MbaA has 
two hydrophobic regions that prevent its easy purification; this is combatted by using a 
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nanodisc which replicates the hydrophobic lipid bilayer and provides a surface for MbaA 
docking (Ritchie et al., 2009). NspS can then be added to the nanodisc-MbaA complex and 
the change in activity can be assessed. If NspS inhibits phosphodiesterase activity, a GGDEF 
domain deletion can then be produced. If NspS requires the GGDEF domain to elicit a 
response, NspS will no longer be able to inhibit phosphodiesterase activity. 
A confounding factor in this research was that while MBP-GGDEF was not able to 
produce c-di-GMP in vitro, pWHIT3 was unable to be expressed in NEB express. 
Overexpression of diguanylate cyclases have been noted as toxic to some E. coli strains 
(Ryjenkov et al., 2005). DcpA and ScrC were characterized as dual-functional diguanylate 
cyclase phosphodiesterases in vivo, but it is unclear if they can function as diguanylate 
cyclases in vitro (Ferreira et al., 2008, Feirer et al., 2015). If MbaA is a functional 
diguanylate cyclase, then ΔmbaA with the pMbaAΔEAL should have produced a more 
biofilm formation than ΔmbaA with the empty vector. There is a possibility that at the time 
the biofilms were scored, biofilm formation was maximal and that there could be no more 
cells incorporated into the biofilm. In order to see if maybe pMbaAΔEAL produces a biofilm 
faster than ΔmbaA, a time course biofilm assay would have to be done. This would determine 
if pMbaAΔEAL and ΔmbaA formed biofilms at a similar rate. If pMbaAΔEAL forms biofilm 
at a faster rate than ΔmbaA, it would be indicative of diguanylate cyclase activity. 
In order to determine if MbaA has diguanylate cyclase activity, c-di-GMP 
concentration can also be measured in a heterologous host. E. coli was used to characterize 
DcpA by overexpressing point mutants in the GGDEF and EAL domains. Glutamate to 
alanine substitutions were made in the EAL domain, to generate AAL, and in the GGDEF 
domain, to generate GGDAF. These substitutions abolish activity of phosphodiesterases and 
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diguanylate cyclases, respectively. When the AAL DcpA was overexpressed c-di-GMP 
concentration was high in E. coli while c-di-GMP concentration was low in the GGDAF 
DcpA overexpression strain. These results indicated that  DcpA has both diguanylate cyclase 
and phosphodiesterase activity (Feirer et al., 2015). E. coli is a good heterologous host 
because it naturally has low c-di-GMP concentration and it has none of the native regulation 
systems found in V. cholerae. In order to see if MbaA is a diguanylate cyclase c-di-GMP 
concentration can be calculated with MBP-GGDEF being expressed in DH5α. If c-di-GMP 
concentration is higher in this strain it would be indicative of an active diguanylate cyclase 
and would explain why we had issues transforming pWHIT3 into NEBexpress. 
Conclusion 
In this study, I set out to determine what role the GGDEF domain plays in MbaA. I 
found that while the GGDEF domain is not a functional diguanylate cyclase in vitro it plays a 
role in regulating phosphodiesterase activity of MbaA. The GGDEF domain inhibits 
phosphodiesterase activity which would decrease the rate that biofilm formation occurs in V. 
cholerae. Biofilm formation is believed to be important for V. cholerae survival within the 
environment and could also help the bacterial infection cycle. Because of how important 
biofilms are to the survival of V. cholerae within the environment, proteins that regulate 
biofilm formation may become important drug targets for treating and preventing V. cholerae 
infections. Clues on allosteric regulation of MbaA may shed light to how V. cholerae 
responds to stressful conditions that require transitions between planktonic and biofilm states. 
My research may also extend beyond V. cholerae research as many other proteobacteria have 
genes that encode NspS-MbaA like protein pairs that have not been characterized. This 
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research could extend to understanding of how these other homologs and regulate c-di-GMP 
concentration within their respective species. 
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